ArticleHeart rhythm O22026
Impact of patent foramen ovale on transvenous lead extraction characteristics and outcomes.
Article in Heart rhythm O2, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Transvenous lead extraction (TLE) may be indicated for cardiac implantable electronic device infection, malfunction, or upgrade. TLE can increase right heart pressures and mobilize debris, resulting in a right-to-left embolism and stroke via a patent foramen ovale (PFO). Objective: This study aimed to identify the prevalence of PFO in patients undergoing TLE and compare the incidence of adverse events. Methods: Intraoperative transesophageal echocardiogram is routinely performed during TLE at the University of California, San Diego, to identify PFO. Between June 2020 and October 2025, 283 patients underwent 289 lead extraction procedures and had intraoperative transesophageal echocardiogram reports available. Patients were compared by PFO status. Results: Of 283 patients, the mean age was 64.98 years (standard deviation ± 15.17); 65.74% were male. PFO was detected in 37 patients (12.80%) but was not associated with different baseline characteristics. Overall, the mean lead count was 2.14 ± 0.51, dwell time was 4.91 ± 4.25 years, and procedural success was 90.66% (odds ratio [OR] 0.43; 95% confidence interval 0.16-1.19; Conclusion: Stroke incidence was not significantly different by PFO status, but mortality was significantly higher in those with PFO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.